A detailed history of Hardin Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hardin Capital Partners, LLC holds 6,123 shares of ABBV stock, worth $1.23 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
6,123
Previous 6,108 0.25%
Holding current value
$1.23 Million
Previous $854 Million 12.08%
% of portfolio
0.54%
Previous 0.56%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $2,457 - $2,989
15 Added 0.25%
6,123 $957 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $945,457 - $1.1 Million
6,108 New
6,108 $854 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hardin Capital Partners, LLC Portfolio

Follow Hardin Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardin Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardin Capital Partners, LLC with notifications on news.